Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China

Stroke. 2020 Apr;51(4):1265-1271. doi: 10.1161/STROKEAHA.119.027980. Epub 2020 Feb 5.

Abstract

Background and Purpose- Multifaceted quality improvement interventions of stroke care have been shown to improve hospital personnel adherence to evidence-based performance measures and subsequent stroke outcomes. This study aimed to evaluate the cost-effectiveness of a multifaceted quality improvement intervention for stroke care in China, the world's largest low- and middle-income country. Methods- A short-term decision tree model and a long-term Markov model were used to analyze the cost-effectiveness of a multifaceted quality improvement intervention for patients with acute ischemic stroke. Outcomes, transition probability, and cost data were obtained from a recent clinical trial and the published literature. The benefit of the intervention was assessed by the costs per quality-adjusted life-years gained in the short- and long-term. One-way and probabilistic sensitivity analyses were performed to assess the uncertainty of the findings. Results- Compared with usual care, a multifaceted quality improvement intervention for stroke care was found to be cost-effective in the first year and highly cost-effective from the second year onward. In the long-term, the intervention yielded a lifetime gain of 0.246 quality-adjusted life-years at an additional cost of Chinese Yuan Renminbi 1510 (US $230), resulting in a cost of Chinese Yuan Renminbi 6138 (US $940) per quality-adjusted life-year gained. Probabilistic sensitivity analysis indicated that the intervention was highly cost-effective in 99.9% of the simulation runs at a willingness-to-pay threshold of Chinese Yuan Renminbi 59 700 (1× gross domestic product per capita of China in 2017, US $9200) per quality-adjusted life-year. Conclusions- A multifaceted quality improvement intervention for stroke care was highly cost-effective in China. The results of this study may be used as a reference for delivering such interventions in low- and middle-income countries and in underserved areas of high-income countries.

Keywords: gross domestic product; quality improvement; quality of care; quality-adjusted life-year; uncertainty.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Ischemia / economics*
  • Brain Ischemia / epidemiology
  • Brain Ischemia / therapy
  • China / epidemiology
  • Cost-Benefit Analysis / methods*
  • Cost-Benefit Analysis / standards
  • Female
  • Humans
  • Male
  • Markov Chains*
  • Quality Improvement / economics*
  • Quality Improvement / standards
  • Stroke / economics*
  • Stroke / epidemiology
  • Stroke / therapy